Dashboard
Manage Tickers

BCDA


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

peering-into-biocardias-recent-short-interest
Peering Into BioCardia's Recent Short Inte...
09/04/2024 17:00:25

why-biocardia-bcda-stock-is-falling-today
Why BioCardia (BCDA) Stock Is Falling Today
08/30/2024 16:12:05

BioCardia shares are trading lower by 12% during Friday's session. The company announced the pricing of an upsized public o...

biocardia-shares-resume-trade-following-circuit-breaker-halt
BioCardia Shares Resume Trade Following Ci...
08/30/2024 14:54:43

biocardia-prices-24m-upsized-public-offering-at-combined-offering-price-of-3-per-share-and-accompanying-warrant
BioCardia Prices 2.4M Upsized Public Offer...
08/30/2024 12:01:57

why-mongodb-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why MongoDB Shares Are Trading Higher By A...
08/30/2024 09:42:20

crude-oil-moves-higher-dollar-general-earnings-miss-estimates
Crude Oil Moves Higher; Dollar General Ear...
08/29/2024 18:30:33

nasdaq-surges-over-1-best-buy-posts-upbeat-earnings
Nasdaq Surges Over 1%; Best Buy Posts Upbe...
08/29/2024 16:19:56

dow-jumps-over-100-points-nvidia-earnings-top-views
Dow Jumps Over 100 Points; Nvidia Earnings...
08/29/2024 14:00:51

why-biocardia-bcda-stock-is-up-95-today
Why BioCardia (BCDA) Stock Is Up 95% Today
08/29/2024 13:28:44

BioCardia shares are trading higher by 95% during Thursday's session. The FDA cleared the company to market its Morph DNA S...

Core News & Articles
Market-Moving News for August 29th
08/29/2024 12:24:45

BCDA: 162% | BioCardia shares are trading higher after FDA cleared the company to market its Morph DNA Steerable Introducer pro...

why-affirm-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket
Why Affirm Shares Are Trading Higher By Ar...
08/29/2024 09:37:19

biocardia-says-fda-has-cleared-company-to-market-its-morph-dna-steerable-introducer-product-family-subject-to-the-general-controls-provisions-of-the-federal-food-drug-and-cosmetic-act---filing
BioCardia Says FDA Has Cleared Company To ...
08/28/2024 21:15:45

hc-wainwright--co-reiterates-buy-on-biocardia-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on BioC...
08/21/2024 17:32:40

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

biocardia-announced-today-that-the-fda-has-approved-a-protocol-amendment-for-the-cardiamp-heart-failure-ii-trial-to-use-proprietary-cell-population-analysis-screening-to-define-treatment
BioCardia Announced Today That The FDA Has...
08/21/2024 11:06:22

hc-wainwright--co-maintains-buy-on-biocardia-adjusts-price-target-to-25-1-15-reverse-stock-split
HC Wainwright & Co. Maintains Buy on BioCa...
08/16/2024 17:53:36

HC Wainwright & Co. analyst Joseph Pantginis maintains BioCardia (NASDAQ:BCDA) with a Buy, adjusts target to $25 from $4 (1...

biocardia-q2-2024-gaap-eps-088-sales-3000k-miss-50000k-estimate
BioCardia Q2 2024 GAAP EPS $(0.88), Sales ...
08/13/2024 20:05:17

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.88) per share. The company reported quarterly sales of $3.000 thousan...

biocardia-says-submitted-510k-for-approval-of-its-patented-morph-dna-steerable-introducer-sheath
BioCardia Says Submitted 510(K) For Approv...
07/30/2024 11:09:54

This product family is intended to provide a pathway through which medical instruments, such as balloon dilatation catheters, g...

hc-wainwright--co-reiterates-buy-on-biocardia-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on BioC...
07/26/2024 11:50:11

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $4 price target.

biocardia-secures-new-patent-for-innovative-heart-procedure-technology
BioCardia Secures New Patent For Innovativ...
07/17/2024 11:04:14

 BioCardia, Inc. (NASDAQ:BCDA), a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular...

biocardia-has-been-granted-us-patent-number-12036371-titled-method-of-accessing-the-left-atrium-with-a-multi-directional-steerable-catheter
BioCardia Has Been Granted U.S. Patent Num...
07/16/2024 19:15:33

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12036371).pn

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION